Abu dhabi: M42, a global health leader driven by technology, artificial intelligence, and genomics, has announced a collaboration with GE HealthCare, a prominent innovator in medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled digital solutions. This partnership aims to enhance diagnostic precision and deliver more personalized patient outcomes, marking a significant advancement in smart healthcare in the UAE.
According to Emirates News Agency, M42 and GE HealthCare will leverage their combined expertise in advanced AI-powered solutions and explore collaborative go-to-market initiatives to provide smarter, more connected healthcare in the region. The focus will be on improving both clinical and operational efficiency. M42's advanced AI, data, and technology platforms, paired with GE HealthCare's expertise in medical technology and product development, will drive the co-development of innovative solutions to address challenges in healthcare systems and support business and operational outcomes.
By integrating AI with multimodal data analysis, M42 and GE HealthCare aim to accelerate product development and further position the region as a growing hub for life sciences innovation. Dimitris Moulavasilis, Group Chief Executive Officer at M42, emphasized the collaboration's potential to disrupt traditional healthcare systems and positively impact people, stating that the partnership will develop and deploy tech-enabled solutions to tackle significant challenges in the healthcare sector.
Konstantinos Deligiannis, President of EAGM (Eurasian and African Growth Markets) at GE HealthCare, highlighted the partnership's commitment to driving precision care through innovation and collaboration. He noted that the collaboration with M42 represents a powerful convergence of advanced AI, data, and clinical expertise, aiming to deliver smarter, more connected healthcare solutions that improve patient outcomes globally.
The partnership leverages the UAE's innovation-friendly ecosystem and reflects the country's ambition to lead in global health innovation by advancing world-class, patient-centered care. By partnering with a global health tech giant, M42 continues to progress smarter, more personalized care for communities in the UAE and beyond.
M42's Diaverum business has utilized 30 years of dialysis expertise to develop an AI-powered digital platform that reduces hospital stays and decreases mortality rates by predicting thrombotic events before they occur. Additionally, M42 has developed the Med42 LLM model, a large language model designed for clinical use cases, available for research as an open-source solution. The company's AIRIS-TB conducts 2,000 AI-powered chest X-ray examinations daily to screen for tuberculosis, a significant increase from the 200 conducted through conventional methods.
